Cristina Ribeiro-Silva

Cristina Ribeiro-Silva

Auto-generated profile, based on publicly available information

Cristina Ribeiro-Silva

Department of Molecular Genetics, Oncode Institute, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CRCristina Ribeiro-Silva
Cristina Ribeiro-Silva
MSMariangela Sabatella
Mariangela Sabatella
AHAngela Helfricht
Angela Helfricht
JMJurgen A. Marteijn
Jurgen A. Marteijn
ATArjan F. Theil
Arjan F. Theil
HLHannes Lans
Hannes Lans
DNA damage sensors DDB2 and XPC initiate global genome nucleotide excision repair (NER) to protect DNA from mutagenesis caused by helix-distorting lesions. XPC recognizes helical distortions by binding to unpaired ssDNA opposite DNA lesions. DDB2 binds to UV-induced lesions directly and facilitates efficient recognition by XPC. We show that not only lesion-binding but also timely DDB2 dissociation is required for DNA damage handover to XPC and swift progression of the multistep repair reaction. DNA-binding-induced DDB2 ubiquitylation and ensuing degradation regulate its homeostasis to prevent excessive lesion (re)binding. Additionally, damage handover from DDB2 to XPC coincides with the arrival of the TFIIH complex, which further promotes DDB2 dissociation and formation of a stable XPC-TFIIH damage verification complex. Our results reveal a reciprocal coordination between DNA damage recognition and verification within NER and illustrate that timely repair factor dissociation is vital for correct spatiotemporal control of a multistep repair process.

4 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CRCristina Ribeiro-Silva
Cristina Ribeiro-Silva
ÖAÖzge Z. Aydin
Özge Z. Aydin
RMRaquel Mesquita-Ribeiro
Raquel Mesquita-Ribeiro
JSJana Slyskova
Jana Slyskova
AHAngela Helfricht
Angela Helfricht
WVWim Vermeulen
Wim Vermeulen
Mutations in SWI/SNF genes are amongst the most common across all human cancers, but efficient therapeutic approaches that exploit vulnerabilities caused by SWI/SNF mutations are currently lacking. Here, we show that the SWI/SNF ATPases BRM/SMARCA2 and BRG1/SMARCA4 promote the expression of p62/GTF2H1, a core subunit of the transcription factor IIH (TFIIH) complex. Inactivation of either ATPase subunit downregulates GTF2H1 and therefore compromises TFIIH stability and function in transcription and nucleotide excision repair (NER). We also demonstrate that cells with permanent BRM or BRG1 depletion have the ability to restore GTF2H1 expression. As a consequence, the sensitivity of SWI/SNF-deficient cells to DNA damage induced by UV irradiation and cisplatin treatment depends on GTF2H1 levels. Together, our results expose GTF2H1 as a potential novel predictive marker of platinum drug sensitivity in SWI/SNF-deficient cancer cells.

1 March 2022 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
AMAlba Muniesa-Vargas
Alba Muniesa-Vargas
ATArjan F. Theil
Arjan F. Theil
CRCristina Ribeiro-Silva
Cristina Ribeiro-Silva
WVWim Vermeulen
Wim Vermeulen
HLHannes Lans
Hannes Lans
The XPG/ERCC5 endonuclease was originally identified as the causative gene for Xeroderma Pigmentosum complementation group G. Ever since its discovery, in depth biochemical, structural and cell biological studies have provided detailed mechanistic insight into its function in excising DNA damage in nucleotide excision repair, together with the ERCC1–XPF endonuclease. In recent years, it has become evident that XPG has additional important roles in genome maintenance that are independent of its function in NER, as XPG has been implicated in protecting replication forks by promoting homologous recombination as well as in resolving R-loops. Here, we provide an overview of the multitasking of XPG in genome maintenance, by describing in detail how its activity in NER is regulated and the evidence that points to important functions outside of NER. Furthermore, we present the various disease phenotypes associated with inherited XPG deficiency and discuss current ideas on how XPG deficiency leads to these different types of disease.

25 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMAlba Muniesa-Vargas
Alba Muniesa-Vargas
CDCarlota Davó-Martínez
Carlota Davó-Martínez
CRCristina Ribeiro-Silva
Cristina Ribeiro-Silva
MWMelanie van der Woude
Melanie van der Woude
KTKaren L. Thijssen
Karen L. Thijssen
HLHannes Lans
Hannes Lans
Congenital nucleotide excision repair (NER) deficiency gives rise to several cancer-prone and/or progeroid disorders. It is not understood how defects in the same DNA repair pathway cause different disease features and severity. Here, we show that the absence of functional ERCC1-XPF or XPG endonucleases leads to stable and prolonged binding of the transcription/DNA repair factor TFIIH to DNA damage, which correlates with disease severity and induces senescence features in human cells. In vivo, in C. elegans, this prolonged TFIIH binding to non-excised DNA damage causes developmental arrest and neuronal dysfunction, in a manner dependent on transcription-coupled NER. NER factors XPA and TTDA both promote stable TFIIH DNA binding and their depletion therefore suppresses these severe phenotypical consequences. These results identify stalled NER intermediates as pathogenic to cell functionality and organismal development, which can in part explain why mutations in XPF or XPG cause different disease features than mutations in XPA or TTDA.